North America Molecular Diagnostics Market By Product & Services (Reagents & Kits, Instruments, Software & Services), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, Hybridization, DNA Sequencing & Next-Generation Sequencing, Microarray), Application (Infectious Diseases, Oncology, Blood Screening, Genetic Tests, Microbiology), End User (Hospital & Academic Laboratories, Reference Laboratories)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Molecular Diagnostics Market, by Product & Services
1.4.2 North America Molecular Diagnostics Market, by Technology
1.4.3 North America Molecular Diagnostics Market, by Application
1.4.4 North America Molecular Diagnostics Market, by End User
1.4.5 North America Molecular Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Executive Summary
Chapter 3. Market Overview
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. North America Molecular Diagnostics Market
4.1 North America Molecular Diagnostics Market by Product & Services
4.1.1 North America Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 North America Molecular Diagnostics Instruments Market by Country
4.1.3 North America Molecular Diagnostics Software & Services Market by Country
Chapter 5. North America Molecular Diagnostics Market by Technology
5.1 Introduction
5.1.1 North America Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 North America Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 North America Hybridization Molecular Diagnostics Market by Country
5.1.4 North America DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 North America Microarray Molecular Diagnostics Market by Country
5.1.6 North America Other Technologies Market by Country
Chapter 6. North America Molecular Diagnostics Market by Application
6.1 Introduction
6.1.1 North America Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 North America Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 North America Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 North America Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 North America Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 North America Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 North America Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 North America Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 North America Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 North America Oncology Molecular Diagnostics Market by Country
6.1.4 North America Oncology Molecular Diagnostics Market by Type
6.1.4.1 North America Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 North America Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 North America Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 North America Other Cancers Molecular Diagnostics Market by Country
6.1.5 North America Blood Screening Molecular Diagnostics Market by Country
6.1.6 North America Genetic Tests Molecular Diagnostics Market by Country
6.1.7 North America Microbiology Molecular Diagnostics Market by Country
6.1.8 North America Other Applications Market by Country
Chapter 7. North America Molecular Diagnostics Market by End User
7.1 Introduction
7.1.1 North America Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 North America Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 North America Molecular Diagnostics Market for Other End Users by Country
Chapter 8. North America Molecular Diagnostics Market by Country
8.1 Introduction
8.2 US Molecular Diagnostics Market
8.2.1 US Molecular Diagnostics Market by Product & Services
8.2.2 US Molecular Diagnostics Market by Technology
8.2.3 US Molecular Diagnostics Market by Application
8.2.3.1 US Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 US Oncology Molecular Diagnostics Market by Type
8.2.4 US Molecular Diagnostics Market by End User
8.3 Canada Molecular Diagnostics Market
8.3.1 Canada Molecular Diagnostics Market by Product & Services
8.3.2 Canada Molecular Diagnostics Market by Technology
8.3.3 Canada Molecular Diagnostics Market by Application
8.3.3.1 Canada Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 Canada Oncology Molecular Diagnostics Market by Type
8.3.4 Canada Molecular Diagnostics Market by End User
8.4 Mexico Molecular Diagnostics Market
8.4.1 Mexico Molecular Diagnostics Market by Product & Services
8.4.2 Mexico Molecular Diagnostics Market by Technology
8.4.3 Mexico Molecular Diagnostics Market by Application
8.4.3.1 Mexico Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 Mexico Oncology Molecular Diagnostics Market by Type
8.4.4 Mexico Molecular Diagnostics Market by End User
8.5 Rest of North America Molecular Diagnostics Market
8.5.1 Rest of North America Molecular Diagnostics Market by Product & Services
8.5.2 Rest of North America Molecular Diagnostics Market by Technology
8.5.3 Rest of North America Molecular Diagnostics Market by Application
8.5.3.1 Rest of North America Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 Rest of North America Oncology Molecular Diagnostics Market by Type
8.5.4 Rest of North America Molecular Diagnostics Market by End User
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense